A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users
- 1 September 2007
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (14), 1923-1932
- https://doi.org/10.1097/qad.0b013e32823f9066
Abstract
To evaluate whether a behavioral intervention, which taught peer education skills, could reduce injection and sexual risk behaviors associated with primary HIV and hepatitis C virus infection (HCV) among young injection drug users (IDU). We conducted a randomized controlled trial involving HIV and HCV antibody-negative IDU, aged 15-30 years, recruited in five United States cities. A six-session, small-group, cognitive behavioral, skills-building intervention in which participants were taught peer education skills (n = 431) was compared with a time-equivalent attention control (n = 423). Baseline visits included interviews for sociodemographic, psychosocial, and behavioral factors during the previous 3 months; HIV and HCV antibody testing; and pre/posttest counselling. Procedures were repeated 3 and 6 months postintervention. The intervention produced a 29% greater decline in overall injection risk 6 months postintervention relative to the control [proportional odds ratio 0.71; 95% confidence limit (CL) 0.52, 0.97], and a 76% decrease compared with baseline. Decreases were also observed for sexual risk behaviors, but they did not differ by trial arm. Overall HCV infection incidence (18.4/100 person-years) did not differ significantly across trial arms (relative risk 1.15; 95% CL 0.72, 1.82). No HIV seroconversions were observed. Interventions providing information, enhancing risk-reduction skills, and motivating behavior change through peer education training can reduce injection risk behaviors, although risk elimination might be necessary to prevent HCV transmission.Keywords
This publication has 42 references indexed in Scilit:
- Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug usersAddiction, 2005
- Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort studyBMJ, 2004
- Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in DublinJournal of Epidemiology and Community Health, 2003
- Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and RisksThe Journal of Infectious Diseases, 2002
- Risk of Hepatitis C Virus Infection among Young Adult Injection Drug Users Who Share Injection EquipmentAmerican Journal of Epidemiology, 2002
- Sharing of drug preparation equipment as a risk factor for hepatitis CAmerican Journal of Public Health, 2001
- Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort studyBMJ, 1998
- Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.American Journal of Public Health, 1996
- Correlates of Hepatitis C Virus Infections among Injection Drug UsersMedicine, 1995
- Incidence of Hepatitis C, Hepatitis B and HIV Infections Among Drug Users in a Methadone-Maintenance ProgrammeAIDS, 1992